image
Healthcare - Biotechnology - NASDAQ - NL
$ 43.36
0.406 %
$ 3 B
Market Cap
-12.9
P/E
Price Target Average
87.34%
Revenue Forecast Estimate
126.70%
EBIT Estimate
--36.85%
Net Income Estimate
30.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Merus N.V.
image
Wall Street analysts predict an average 1-year price target for MRUS of $81.2 , with forecasts ranging from a low of $58 to a high of $99 .
MRUS Lowest Price Target Wall Street Target
58 USD 33.76%
MRUS Average Price Target Wall Street Target
81.2 USD 87.34%
MRUS Highest Price Target Wall Street Target
99 USD 128.32%
Price
Max Price Target
Min Price Target
Average Price Target
1001009090808070706060505040403030Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart MRUS

image
$1.0b$1.0b$900.0m$900.0m$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MRUS

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)($900.0m)($900.0m)($1.0b)($1.0b)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MRUS

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)2016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029